PAB
@Rory, The clinical trials at Yale for Deoxymab are looking extremely positive, this progress can be accessed in Medical Journal Online.In my view they will have a huge announcement on this very soon!! PAB hinted on this in their annual report.The outcomes should be very big globally for PAB..Certainly worth more than their $4M Cap.
"Patrys believes that Deoxymab, and its sister antibody, 5C6, may have application across a wide range of malignancies such as gliomas, melanomas, prostate, breast, pancreatic and ovarian cancers."(WORLDWIDE).
THIS IS WHAT TO WATCH FOR IN THE COMING ANNOUNCEMENT.
GL
- Forums
- ASX - Day Trading
- Daytrading October 6 afternoon
Daytrading October 6 afternoon, page-111
-
- There are more pages in this discussion • 172 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
AHK
ARK MINES LIMITED
Ben Emery, Executive Director
Ben Emery
Executive Director
SPONSORED BY The Market Online